340B Fight Escalates As Biden Administration Seeks Refunds From Manufacturers, Threatens Them With Fines

20 May 2021

Lilly, AstraZeneca, Novartis, Sanofi, Novo Nordisk and United Therapeutics ordered by HRSA to resume discounts to 340B contract pharmacies and refund past 'overcharges.'

Compliance — Dispute May Ultimately Bring Clarity To 340B Rules

340B Fight Escalates As Biden Administration Seeks Refunds From Manufacturers, Threatens Them With Fines

More from Legal & IP

More from Pink Sheet